Unknown OBSERVATIONAL NCT03210467

The Changes of Plasmacytoid Dendritic Cells Frequency and Function During Antiviral Therapy

The Changes of Plasmacytoid Dendritic Cells Frequency and Function During Pegylated Interferon α-2a and Entecavir(ETV) Treatment in Patients With Chronic Hepatitis B.

Sponsor: Beijing Ditan Hospital

Conditions Chronic Hepatitis B Infection

Updated 7 times since 2017 Last updated: Jul 4, 2017 Started: Jan 31, 2016 Primary completion: Dec 31, 2017 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03210467, this observational or N/A phase trial focuses on Chronic Hepatitis B Infection and remains ongoing. Sponsored by Beijing Ditan Hospital, it has been updated 7 times since 2016, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Aug 2019 — Jan 2021 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jun 2018 — Aug 2019 [monthly]

Recruiting

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Ditan Hospital

Data source: Beijing Ditan Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China